Improving chip momentum is worth monitoring, but strength and a well-defined entry are different questions.
What changed this week
Against the September 29 readings in the previous edition, all four RSI readings have improved. AMD is now slightly above 70 rather than in the mid-60s, while AVGO remains below 50. NVDA's histogram is larger; AMD's and ARM's remain positive but are smaller. [Dated technical / social evidence] [Previous edition values]
Why this group, why now
The four-name watch remains selective. NVDA and ARM have above-midpoint RSI with positive histograms, while AMD combines stronger directional readings with an extension warning. AVGO is still the incomplete member of the group. [Dated technical / social evidence] [Event / company context]
A larger RSI reading does not make an entry cheaper or safer. In particular, AMD's renewed strength should shift attention toward orderly consolidation rather than treating a rising indicator as permission to chase. None of these readings establishes structural support or a fresh scanner fire. [Dated technical / social evidence]
The evidence at a glance
RSI series date: Oct 2, 2026. MACD and ADX were retrieved Oct 5 from the same technical response; their individual dates are not exposed. Buzz measures attention, not bullish sentiment.
| Ticker | RSI · 14 | MACD hist. | ADX · 14 | Social buzz | Evidence |
|---|---|---|---|---|---|
| NVDA ↗ | 62.9 | 0.83 | 15.9 | 83/100 ↗Reddit + X | Oct 2 snapshot |
| AMD ↗ | 70.1 | 4.39 | 25.8 | 80/100 ↗Reddit + X | Oct 2 snapshot |
| ARM ↗ | 58.5 | 1.26 | 19.6 | Outside returned setNo score carried forward | Oct 2 snapshot |
| AVGO ↗ | 47.6 | 0.93 | 21.4 | 76/100 ↗Reddit + X | Oct 2 snapshot |
Positive histogram does not mean a fresh crossover. ADX measures strength, not direction; the per-name discussion also checks the directional indices. Histogram magnitudes are not comparable across tickers.
The names and the setup
NVDA ↗
Improving momentumRSI has risen to 62.9 and the histogram remains positive. Positive directional movement exceeds negative, but ADX remains low, so momentum improvement is not the same as an established strong trend. [Dated evidence]
What to watch: Look for above-midpoint RSI to persist through a pullback, with the histogram staying positive. Recheck the chart before defining any entry or invalidation price.
AMD ↗
Extension disciplineRSI is 70.1, up from 65.5 in the prior snapshot. Positive directional movement dominates and ADX is 25.8, while the positive histogram is smaller than before. This is strength with a reason for patience, not an automatic sell or buy. [Dated evidence]
What to watch: An orderly reset that retains constructive momentum would be more useful than an entry justified only by a high RSI. Watch for a reversal in directional dominance.
ARM ↗
Recovery still developingRSI has improved to 58.5. Its positive histogram and positive directional advantage are constructive, but ADX is below 20 and the histogram is smaller than in the previous snapshot. [Dated evidence]
What to watch: Monitor whether above-midpoint RSI survives a quieter session and whether trend strength develops without renewed extension.
AVGO ↗
Reclaim still missingRSI remains below 50 despite improving to 47.6. Its histogram is positive, but negative directional movement exceeds positive. The evidence still does not match the stronger members of this group. [Dated evidence]
What to watch: Require a sustained midpoint reclaim and better directional alignment before calling this a broad group confirmation.
News and event context
Barron's links Nvidia's latest stock-market attention to supplier Foxconn's sales update. That is supporting industry context, not proof that a favorable entry exists in all four names. Barron's via connected news feed ↗ (2026-10-05)
Reuters describes a debate over the value of AI chips and infrastructure as financing collateral. The report is a counterweight to a demand-only narrative; financing assumptions should not be treated as risk-free. Reuters via connected news feed ↗ (2026-10-01)
What would confirm it
Look for constructive readings to survive consolidation in NVDA and ARM, a controlled rather than vertical move in AMD, and an actual RSI midpoint reclaim with improved directional alignment in AVGO. These are monitoring conditions, not an executable trade signal.
What would change our view
A sustained loss of midpoint RSI in the stronger names, a negative histogram developing alongside deteriorating directional readings, or continued AVGO weakness would undermine the group thesis. [Dated technical / social evidence]
The risk to respect
Industry enthusiasm can persist while entry quality deteriorates. Concentrated AI exposure and financing uncertainty can affect multiple names together; four tickers do not make four independent risks. Related news context.
The next review
Review the next completed-session readings rather than substituting Monday's partial session. Any price-based trade plan needs separately verified support, invalidation and target levels.
These are editorial monitoring conditions, not backtested selection rules. No entry price, verified structural support, stop, target or reward-to-risk estimate is supplied.
Completed-session indicators and subsequent headlines have different timestamps. This frozen weekly edition does not update intraday.
Inspect the evidence ledger ↗